Genmab 7.25% 2033 bond (US37230JAB89)
As of 2026-10-30 · rebuilt daily
https://bondscovery.com/bond/US37230JAB89
Genmab's 7.25% USD bond maturing 2033-12-15 (US37230JAB89) yields 6.65% to worst as of 2026-10-30. That is 174 bp over the US Treasury curve at the same maturity and 2 bp below the fitted US High Yield (BB–D) Healthcare & Pharmaceuticals Corporate Bond (USD) curve.
Against its curves
Each curve's fitted yield at this bond's maturity (at its call date, where it is priced to call), and the bond's spread to it.
| Curve | Curve yield | Spread |
|---|---|---|
| US Treasury Yields | 4.91% | +174 bp |
| US High Yield (BB–D) Healthcare & Pharmaceuticals Corporate Bond Yields (USD) | 6.67% | -2 bp |
| US High Yield (BB–D) Corporate Bond Yields (USD) | 7.21% | -57 bp |
The bond
| ISIN | US37230JAB89 |
|---|---|
| Issuer | Genmab |
| Issuer type | Corporate |
| Country | Denmark |
| Sector | Healthcare & Pharmaceuticals |
| Currency | USD |
| Coupon | 7.25% |
| Coupon frequency | Semiannual |
| Maturity | 2033-12-15 |
| Rating band | BB+–D (High Yield) |
| Yield to worst | 6.65% |